Development of Enteric-coated Tablets of Sodium 4,4'-(propnadiamido)dibenzoate-Reference-Cited by-同舟云学术

Development of Enteric-coated Tablets of Sodium 4,4'-(propnadiamido)dibenzoate

Published:2022-05-30 Issue:2 Volume:11 Page:109-117
ISSN:2658-5049
Container-title:Drug development & registration
language:
Short-container-title:Razrabotka i registraciâ lekarstvennyh sredstv

Author:

Kotsur Ju. M.¹^ORCID,Flisyuk E. V.¹^ORCID,Narcevich I. A.¹^ORCID

Affiliation:

1. Saint-Petersburg State Chemical-Pharmaceutical University

Publisher

Center of Pharmaceutical Analytics Ltd

Subject

Drug Discovery,Pharmaceutical Science

Reference11 articles.

1. Mazova N. V., Marchenko A. L., Smehova I. E. Research and Development of the Composition and Technology Receving of Granules of Omeprazol in the Fluid Bed Apparatus. Drug development & registration. 2019;8(2):74–79. (In Russ.) DOI: 10.33380/2305-2066-2019-8-2-74-79.

2. Mohapatra S. K., Sahoo R. N., Mallick S., Mohapatra R. Enteric Dissolution Enhancement of Engineered Gastro Resistant Omeprazole Tablets using Hydroxypropyl Methylcellulose Acetate Succinate. Indian Journal of Pharmaceutical Education and Research. 2021;55(3):677-684. DOI: 10.5530/ijper.55.3.139.

3. Zhang X., Cheng Y., Li X., Tan X., Shi L., Shi X., Xie C., Li J. Efficacy and safety of the Chinese herbal formula Hewei Jiangni recipe for NERD with cold-heat complex syndrome: study protocol for a double-blinded randomized controlled trial. Trials. 2021;22(1):545. DOI: 10.1186/s13063-021-05471-7.

4. Moutaharrik S., Maroni A., Melocchi A., Zema L., Foppoli A., Cerea M., Palugan L., Neut C., Siepmann F., Siepmann J., Gazzaniga A. Oral colon delivery platform based on a novel combination approach: Design concept and preliminary evaluation. Journal of Drug Delivery Science and Technology. 2021;66:102919. DOI: 10.1016/j.jddst.2021.102919.

5. Nandhakumar S., Sugreevudu G., Harikrishnan N. Formulation design and Evaluation of Extended-Release Tablets of Oxybutynin for Effective Management of Overactive Bladder Syndrome. Research Journal of Pharmacy and Technology. 2021;14(12):6558–6564. DOI: 10.52711/0974-360X.2021.01135.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biowaiver as a Bioequivalence Study Option;Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products. Regulatory Research and Medicine Evaluation;2023-08-01